Drugmakers Need Not Stress Over Post-FDASIA SQA Checks
BALTIMORE — While the new FDA user fee bill links supplier quality agreements (SQA) to drugmakers’ oversight responsibilities for the first time, it’s not likely such accords will be the focus of inspections any more than they are now, FDA officials say.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.